Related Experiment Video
Updated: Sep 13, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Expression profiles of pancreatic cancer cell lines infected with antisense K-ras-expressing adenoviral vector
Shumpei Ohnami1, Kazunori Aoki, Kimiko Yoshida
1Genetics Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Abstract:
The point mutations of the K-ras gene occur in as high as 70-90% of the cases with adenocarcinoma of the pancreas and apparently represent one of the key and early events in the carcinogenesis. However, the specific influence of the K-ras activation on global gene expression profiles in pancreatic cancer cells has not been elucidated. In this study, to promote elucidation of the K-ras-triggered molecular cascade(s) in pancreatic cancer, four pancreatic cancer cell lines with K-ras point mutations were infected with an adenovirus vector expressing an antisense K-ras RNA (AxCA-AS), and the change of gene expression was analyzed by oligonucleotide-based microarrays containing 12,626 genes. Among the genes showing more than 2-fold differences in the expression levels between the control- and antisense-K-ras-transduced cells, 7 genes were commonly up-regulated and 4 genes were commonly down-regulated in three or all of the four pancreatic cancer cell lines transduced with AxCA-AS. The altered gene expression levels observed by microarrays were confirmed by real-time RT-PCR methods. Then, the expression of the 4 down-regulated genes was examined in the untransduced surgical specimens of pancreatic cancer. The G-protein coupled receptor RE2 and phenylethanolamine N-methyltransferase had negligible expression levels in all pancreatic cancers, whereas the syntaxin 1A and p120 catenin isoform were significantly up-regulated in pancreatic cancers containing K-ras mutations compared with a pancreatic cancer with wild type K-ras gene. The transcriptional regulation of those genes may be a part of the molecular cascades triggered by K-ras activation leading to the development and/or progression of pancreatic cancer.
Insights
K-ras gene mutations are early events in pancreatic cancer. Inhibiting K-ras altered gene expression, identifying potential therapeutic targets like syntaxin 1A and p120 catenin in pancreatic adenocarcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- K-ras gene point mutations are frequent in pancreatic adenocarcinoma, indicating their role in early carcinogenesis.
- The precise impact of K-ras activation on global gene expression in pancreatic cancer remains unclear.
Purpose of the Study:
- To investigate the molecular cascades triggered by K-ras activation in pancreatic cancer cells.
- To identify specific genes whose expression is altered due to K-ras mutations.
Main Methods:
- Utilized adenovirus-mediated antisense K-ras RNA (AxCA-AS) to inhibit K-ras in four pancreatic cancer cell lines.
- Analyzed global gene expression changes using oligonucleotide microarrays (12,626 genes).
- Validated microarray findings with real-time RT-PCR and examined gene expression in surgical specimens.
Main Results:
- Commonly identified 7 up-regulated and 4 down-regulated genes in K-ras-mutated cell lines after AxCA-AS transduction.
- Syntaxin 1A and p120 catenin isoform were significantly up-regulated in K-ras-mutated pancreatic cancers.
- RE2 and phenylethanolamine N-methyltransferase showed negligible expression in pancreatic cancers.
Conclusions:
- K-ras activation influences global gene expression profiles in pancreatic cancer.
- Syntaxin 1A and p120 catenin isoform up-regulation may be part of K-ras-triggered molecular pathways in pancreatic cancer development.
- Transcriptional regulation of these genes could be crucial for pancreatic cancer progression.

